XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash Flow From Operating Activities:      
Net income (loss) $ 11,267 $ (21,743) $ 182,692
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Gain on sale or write down of assets (36,895) (15,192) (171,530)
Loss (gain) on foreign currency transactions 13,378 15,108 (12,399)
Loss on debt extinguishment 0 5,219 0
Depreciation and amortization 18,579 15,588 30,658
Provision for doubtful accounts 984 0 0
Equity in earnings from unconsolidated joint ventures 379 2,313 (1,513)
Distribution of income from unconsolidated joint ventures 1,782 0 0
Changes in assets and liabilities, net of dispositions:      
Other assets (3,450) 10,814 (104,163)
Related party receivables (327) (46,191) (11,894)
Accrued interest payable (531) 2,338 (2,316)
Accounts payable and other liabilities (1,668) (8,895) (81,867)
Net cash provided by (used in) operating activities 3,498 (40,641) (172,332)
Cash Flow From Investing Activities:      
Collection of notes receivable 8,251 19,755 6,541
Originations and advances on notes receivable (33,015) (21,434) (16,801)
Acquisition of real estate 0 (3,422) (10,558)
Development and renovation of real estate (17,505) (33,730) (85,055)
Deferred leasing costs (2,603) 0
Proceeds from sale of assets 40,982 28,622 253,498
Distribution from unconsolidated joint ventures 8,086 6,504 0
Net cash provided by (used in) by investing activities 4,196 (3,705) 147,625
Cash Flow From Financing Activities:      
Proceeds from mortgages, other notes and bonds payable 30,727 103,800 182,558
Payments on mortgages, other notes and bonds payable (33,415) (74,718) (124,616)
Debt extinguishment costs 0 (3,799) 0
Deferred financing costs (1,297) (4,241) (5,257)
Repurchase of preferred stock 0 0 (9,001)
Preferred stock dividends 0 0 (900)
Net cash (used in) provided by financing activities (3,985) 21,042 42,784
Net increase (decrease) in cash and cash equivalents 3,709 (23,304) 18,077
Cash, cash equivalents and restricted cash, beginning of period 83,311 106,615 88,538
Cash, cash equivalents and restricted cash, end of period $ 87,020 $ 83,311 $ 106,615